Overview
- In a Nov. 9 interview published by The Sunday Times, Ramsay said there is "no way" he will create special or smaller‑portion menus for guests using Ozempic or Mounjaro.
- He called the concept "absolute bulls---" and argued that diners are responsible for "eating too much in the first place."
- Heston Blumenthal’s The Fat Duck introduced a reduced‑portion "Mindful Experience" in September for patrons on weight‑loss drugs, illustrating a split in industry approaches.
- Coverage explains that Ozempic (semaglutide) and Mounjaro (tirzepatide) treat type 2 diabetes, suppress appetite, and are widely used for weight loss.
- Ramsay also criticized influencer phone use in dining rooms and said his new fine‑dining venue Bonheur "will not be flooded with TikTokers."